Increased Expression of Cathepsin D in Retrosplenial Cortex of MK-801-Treated Rats

Single administration of a high dose of an uncompetitive NMDA receptor antagonist-dizocilpine maleate (MK-801)-results in transient neuronal vacuolization and cell death in retrosplenial cortex in rodents. In this study expression of cathepsin D (CatD), a major lysosomal aspartic protease, was investigated in brains of female rats treated with 1, 5, or 10 mg/kg of MK-801. Northern blot analysis demonstrated that the CatD mRNA level was moderately increased in retrosplenial cortex 24 h-7 days after the treatment. Concomitantly, increased CatD immunoreactivity was observed, predominantly in the degenerating neurons in layer III of retrosplenial cortex. Neuronal response was spatially distinguished from glial reactivation marked by increased mRNA and protein levels of glial fibrillary acidic protein, as demonstrated by Northern blot and immunohistochemistry in retrosplenial cortex 24 h-7 days after MK-801 treatment. These data suggest that activation of the lysosomal proteolytic system of neurons may play a role in MK-801-evoked neurodegeneration.

[1]  A. Lajtha,et al.  The Distribution of Cathepsin D Activity in Adult and Aging Human Brain Regions , 1992, Journal of neurochemistry.

[2]  R. Nixon,et al.  The endosomal-lysosomal system of neurons: new roles , 1995, Trends in Neurosciences.

[3]  J. Olney,et al.  Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. , 1989, Science.

[4]  J. Olney,et al.  NMDA antagonist neurotoxicity: mechanism and prevention. , 1991, Science.

[5]  H. Bernstein,et al.  Immunodetection of cathepsin D in neuritic plaques found in brains of patients with dementia of Alzheimer type. , 1989, Journal fur Hirnforschung.

[6]  P. Gass,et al.  Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-d-aspartate receptor antagonist MK-801 , 1993, Neuroscience.

[7]  L. Kaczmarek,et al.  Elevated Cathepsin D Expression in Kainate-Evoked Rat Brain Neurodegeneration , 1995, Experimental Neurology.

[8]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[9]  A. Matus,et al.  Age-related increase in a cathepsin D like protease that degrades brain microtubule-associated proteins. , 1987, Biochemistry.

[10]  L. Noble,et al.  MK‐801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex , 1991, Annals of neurology.

[11]  B. Scatton Excitatory amino acid receptor antagonists: a novel treatment for ischemic cerebrovascular diseases. , 1994, Life sciences.

[12]  E. Bird,et al.  Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin , 1990, Brain Research.

[13]  I. Allen,et al.  THE CELLULAR ORIGIN OF LYSOSOMAL ENZYMES IN THE PLAQUE IN MULTIPLE SCLEROSIS: A COMBINED HISTOLOGICAL AND BIOCHEMICAL STUDY , 1978, Neuropathology and applied neurobiology.

[14]  G. Paxinos The Rat nervous system , 1985 .

[15]  Jinhe Li,et al.  Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system , 1995, Neuron.

[16]  A. Haase,et al.  Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes , 1991, Journal of virology.

[17]  H. Nakanishi,et al.  Age-Related Changes in Activities and Localizations of Cathepsins D, E, B, and L in the Rat Brain Tissues , 1994, Experimental Neurology.

[18]  W. Whetsell,et al.  Immunocytochemical localization of cathepsin D in rat neural tissue , 1981, Brain Research.

[19]  C. Peters,et al.  Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. , 1995, The EMBO journal.

[20]  E. Castrén,et al.  Differential Effects of MK-801 on Brain-Derived Neurotrophic Factor mRNA Levels in Different Regions of the Rat Brain , 1993, Experimental Neurology.

[21]  D. Choi,et al.  Bench to bedside: the glutamate connection. , 1992, Science.

[22]  H. Terayama,et al.  Cathepsin D stimulates DNA synthesis and mitosis in mouse liver in vivo. , 1984, Experimental cell research.

[23]  R. Bullock Strategies for Neuroprotection with Glutamate Antagonists , 1995, Annals of the New York Academy of Sciences.

[24]  R. Nixon,et al.  Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Olney Excitotoxicity and N‐methyl‐D‐Aspartate receptors , 1989 .

[26]  A. Lajtha,et al.  Increase in cathepsin D activity in rat brain in aging , 1989, Journal of neuroscience research.

[27]  B. Meldrum Amino acids as dietary excitotoxins: A contribution to understanding neurodegenerative disorders , 1993, Brain Research Reviews.

[28]  J. Olney,et al.  Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia? , 1995, Biological Psychiatry.

[29]  J. Olney,et al.  Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity , 1993, Biological Psychiatry.

[30]  H. Rochefort,et al.  Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[31]  C. Peters,et al.  Mouse cathepsin D gene: molecular organization, characterization of the promoter, and chromosomal localization. , 1994, DNA and cell biology.

[32]  H. Nakanishi,et al.  Transient Forebrain Ischemia Induces Increased Expression and Specific Localization of Cathepsins E and D in Rat Hippocampus and Neostriatum , 1993, Experimental Neurology.

[33]  A. Cataldo,et al.  Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  L. Kaczmarek,et al.  Glutamate receptors in cortical plasticity: molecular and cellular biology. , 1997, Physiological reviews.

[35]  S. Heinemann,et al.  Cloned glutamate receptors. , 1994, Annual review of neuroscience.

[36]  J. Olney,et al.  Neuronal Vacuolization and Necrosis Induced by the Noncompetitive N-methyl-d-aspartate (NMDA) Antagonist MK(+)801 (Dizocilpine Maleate): A Light and Electron Microscopic Evaluation of the Rat Retrosplenial Cortex , 1993, Experimental Neurology.

[37]  M. Norenberg,et al.  Astrocyte Responses to CNS Injury , 1994, Journal of neuropathology and experimental neurology.

[38]  L. Iversen,et al.  Phencyclidine, dizocilpine, and cerebrocortical neurons. , 1990, Science.

[39]  J. Miller,et al.  Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex , 1995, Brain Research.

[40]  M. Shelanski,et al.  Sequence of a cDNA clone encoding mouse glial fibrillary acidic protein: structural conservation of intermediate filaments. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[41]  O'Callaghan Jp,et al.  Reactive gliosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex: GFAP evaluation by sandwich ELISA and immunocytochemistry. , 1995 .

[42]  R. Nixon,et al.  Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease , 1994, Brain Research.